Exagen (XGN) Profit After Tax (2018 - 2026)

Exagen has reported Profit After Tax for 9 years, with the latest figure at -$4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 5.73% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$20.2 million (down 30.04% YoY), and the FY2025 full-year result was -$20.0 million, down 31.99% from the prior year.
• Profit After Tax for Q1 2026 stood at -$4.0 million, up from -$4.7 million in the prior quarter.
• The five-year high for Profit After Tax was -$3.0 million in Q2 2024, with the low at -$14.7 million in Q2 2022.
• Historically, Profit After Tax has averaged -$6.5 million across 5 years, with a median of -$5.0 million in 2024.
• Annual changes were most pronounced in 2022 — Profit After Tax tumbled 128.78% — and 2023, when it soared 65.82%.
• Exagen's Profit After Tax stood at -$14.4 million in 2022, then jumped by 61.17% to -$5.6 million in 2023, then jumped by 32.51% to -$3.8 million in 2024, then retreated by 24.25% to -$4.7 million in 2025, then climbed by 15.11% to -$4.0 million in 2026.
• The last three Profit After Tax figures came in at -$4.0 million (Q1 2026), -$4.7 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.